JENSCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
JENSCARE-B: CONTINUING CONNECTED TRANSACTIONSUPPLEMENTAL ANNOUNCEMENT ON LOAN AGREEMENTFOR REPURCHASE OF INTERESTS IN THE ESOP PLATFORM
JENSCARE-B: PROXY FORM FOR THE 2024 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, SEPTEMBER 19, 2024
JENSCARE-B: NOTICE OF 2024 FIRST EXTRAORDINARY GENERAL MEETING
JENSCARE-B: (1) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (2) PROPOSED GRANTING OF GENERAL MANDATE TO REPURCHASE H SHARES;(3) PROPOSED AMENDMENT OF THE H SHARE AWARD SCHEME; (4) PROPOSED AMENDMENTS OF CERTAIN RULES AND PROCEDURES OF THE COMPANY; AND (5) NOTI
JENSCARE-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024
JENSCARE-B: NOTICE OF BOARD MEETING
JENSCARE-B: CONTINUING CONNECTED TRANSACTION - LOAN AGREEMENT FOR REPURCHASE OF INTERESTS IN THE ESOP PLATFORM
JENSCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
JENSCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
JENSCARE-B: VOLUNTARY ANNOUNCEMENT RESULTS OF SIX-MONTH CLINICAL FOLLOW-UP OF LUX-VALVE PLUS TRAVEL II STUDY RELEASED
JENSCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
JENSCARE-B: (1) POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING HELD ON MAY 31, 2024; (2) RE-ELECTION OF DIRECTORS OF THE SECOND SESSION OF THE BOARD; AND (3) RE-ELECTION OF SUPERVISORS OF THE SECOND SESSION OF THE BOARD OF SUPERVISORS
JENSCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
JENSCARE-B: PROXY FORM FOR THE 2023 ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 31, 2024
JENSCARE-B: NOTICE OF 2023 ANNUAL GENERAL MEETING
JENSCARE-B: 1)2023 REPORT OF THE BOARD OF DIRECTORS 2)2023 REPORT OF THE BOARD OF SUPERVISORS 3)2023 AUDITED FINANCIAL STATEMENTS 4)2023 ANNUAL REPORT 5)2023 FINANCIAL ACCOUNTS REPORT 6)2024 FINANCIAL BUDGET 7)2023 ANNUAL PROFIT DISTRIBUTION PLAN 8)REAPPOINTMENT OF AU
JENSCARE-B: 2023 Annual Report
JENSCARE-B: INSIDE INFORMATIONLUX-VALVE REGISTRATION APPLICATIONNOT APPROVED BY THE NMPA
JENSCARE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
No Data
No Data